$EXPI
EXP World Holdings, Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024014851 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $1.231B $1.215B
YoY Change 1.37% -1.97%
Cost Of Revenue $911.0K $1.131B
YoY Change -99.92% -1.3%
Gross Profit $1.230B $83.60M
YoY Change 1371.62% -10.23%
Gross Profit Margin 99.93% 6.88%
Selling, General & Admin $64.18M $81.76M
YoY Change -21.5% -12.17%
% of Gross Profit 5.22% 97.8%
Research & Development $13.80M $15.48M
YoY Change -10.83%
% of Gross Profit 1.12% 18.52%
Depreciation & Amortization $2.379M $2.790M
YoY Change -14.73% 0.83%
% of Gross Profit 0.19% 3.34%
Operating Expenses $1.240B $1.213B
YoY Change 2.22% -2.12%
Operating Profit -$8.334M $1.863M
YoY Change -547.34% 7065.38%
Interest Expense -$281.0K -$400.0K
YoY Change -29.75% 21.58%
% of Operating Profit -21.47%
Other Income/Expense, Net $520.0K $354.0K
YoY Change 46.89% -241.04%
Pretax Income -$7.814M $2.217M
YoY Change -452.46% -1085.33%
Income Tax -$1.333M $868.0K
% Of Pretax Income 39.15%
Net Earnings -$8.506M $1.349M
YoY Change -730.54% -69.35%
Net Earnings / Revenue -0.69% 0.11%
Basic Earnings Per Share -$0.06 $0.01
Diluted Earnings Per Share -$0.06 $0.01
COMMON SHARES
Basic Shares Outstanding 153.3M 153.8M
Diluted Shares Outstanding 153.3M 158.2M

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.4M $120.1M
YoY Change 8.6% -10.74%
Cash & Equivalents $130.4M $120.1M
Short-Term Investments
Other Short-Term Assets $74.01M $66.30M
YoY Change 11.62% 0.73%
Inventory
Prepaid Expenses
Receivables $105.1M $113.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $309.6M $299.8M
YoY Change 3.26% -6.36%
LONG-TERM ASSETS
Property, Plant & Equipment $11.49M $13.86M
YoY Change -17.13% -21.63%
Goodwill $19.87M $24.88M
YoY Change -20.15% -6.17%
Intangibles $6.322M $11.46M
YoY Change -44.82% 27.67%
Long-Term Investments
YoY Change
Other Assets $85.37M $72.80M
YoY Change 17.26% 11.51%
Total Long-Term Assets $123.0M $123.1M
YoY Change -0.01% 1.96%
TOTAL ASSETS
Total Short-Term Assets $309.6M $299.8M
Total Long-Term Assets $123.0M $123.1M
Total Assets $432.6M $422.9M
YoY Change 2.31% -4.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.65M $9.300M
YoY Change 14.48% -6.16%
Accrued Expenses $109.5M $108.4M
YoY Change 1.06% -7.84%
Deferred Revenue $67.06M $54.21M
YoY Change 23.7% 2.96%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $221.5M $171.9M
YoY Change 28.85% -4.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $5.000K
YoY Change -100.0% -99.82%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $5.000K
YoY Change -100.0% -99.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $221.5M $171.9M
Total Long-Term Liabilities $0.00 $5.000K
Total Liabilities $221.5M $171.9M
YoY Change 28.85% -6.46%
SHAREHOLDERS EQUITY
Retained Earnings -$51.10M $11.97M
YoY Change -526.93% -65.43%
Common Stock $924.6M $757.0M
YoY Change 22.14% 33.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $211.1M $249.8M
YoY Change
Total Liabilities & Shareholders Equity $432.6M $422.9M
YoY Change 2.31% -4.08%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$8.506M $1.349M
YoY Change -730.54% -69.35%
Depreciation, Depletion And Amortization $2.379M $2.790M
YoY Change -14.73% 0.83%
Cash From Operating Activities $46.00M $22.30M
YoY Change 106.27% 1.24%
INVESTING ACTIVITIES
Capital Expenditures $2.292M $1.500M
YoY Change 52.8% -231.0%
Acquisitions
YoY Change
Other Investing Activities -$298.0K $200.0K
YoY Change -249.0% -102.07%
Cash From Investing Activities -$2.590M -$1.300M
YoY Change 99.23% -87.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -41.91M -59.90M
YoY Change -30.03% -8.08%
NET CHANGE
Cash From Operating Activities 46.00M 22.30M
Cash From Investing Activities -2.590M -1.300M
Cash From Financing Activities -41.91M -59.90M
Net Change In Cash 1.497M -38.90M
YoY Change -103.85% -27.9%
FREE CASH FLOW
Cash From Operating Activities $46.00M $22.30M
Capital Expenditures $2.292M $1.500M
Free Cash Flow $43.71M $20.80M
YoY Change 110.13% -10.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153551386
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130432000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125873000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
65308000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
44020000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1334000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2204000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105148000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85343000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7709000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9275000
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
988000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1964000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
309585000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
266475000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11488000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12967000
CY2024Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
10832000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7410000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6322000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7012000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
69937000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
69253000
CY2024Q3 us-gaap Goodwill
Goodwill
19866000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
4599000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
5569000
CY2024Q3 us-gaap Assets
Assets
432629000
CY2023Q4 us-gaap Assets
Assets
385668000
CY2024Q3 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
10647000
CY2023Q4 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
8788000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67060000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44550000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
109531000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86483000
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
34000000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
274000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1809000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
221532000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
141640000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20000
CY2024Q3 us-gaap Liabilities
Liabilities
221532000
CY2023Q4 us-gaap Liabilities
Liabilities
141660000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
192559288
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153551386
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183606708
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154669037
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
924570000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
804833000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39007902
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28937671
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
661840000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
545559000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51095000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16769000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-540000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
332000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
211097000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
242839000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1169000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211097000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244008000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
432629000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385668000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1231187000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1212793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3469485000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3292362000
CY2024Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1143535000
CY2023Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1130070000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3205949000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3042523000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61390000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60363000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
185132000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179905000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13804000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15480000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43413000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44428000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2792000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3175000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8962000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8962000
CY2024Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18000000
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
34000000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1239521000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1209088000
us-gaap Operating Expenses
OperatingExpenses
3477456000
us-gaap Operating Expenses
OperatingExpenses
3275818000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8334000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3705000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7971000
us-gaap Operating Income Loss
OperatingIncomeLoss
16544000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
801000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
702000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3738000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2871000
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-281000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-354000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-804000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-839000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
520000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
348000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2934000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2032000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7814000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4053000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5037000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18576000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1333000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1788000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3508000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2962000
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6481000
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2265000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8545000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
15614000
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2025000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-916000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3217000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3390000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-8506000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1349000
us-gaap Profit Loss
ProfitLoss
-11762000
us-gaap Profit Loss
ProfitLoss
12224000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.04
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.04
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153259842
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153392005
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153858160
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153065727
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153259842
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158183888
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153858160
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156834985
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-8506000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1349000
us-gaap Profit Loss
ProfitLoss
-11762000
us-gaap Profit Loss
ProfitLoss
12224000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
915000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-527000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-872000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
180000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7591000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
822000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12634000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12404000
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211097000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250926000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211097000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250926000
us-gaap Profit Loss
ProfitLoss
-11762000
us-gaap Profit Loss
ProfitLoss
12224000
us-gaap Depreciation
Depreciation
5887000
us-gaap Depreciation
Depreciation
6299000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1855000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1849000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
472000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-870000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-2211000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-804000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-839000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
28067000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
29912000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5961000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7659000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
85997000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
104548000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-684000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
3435000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18935000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23401000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1978000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3966000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-22510000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-16421000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1858000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1069000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21114000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
28039000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4692000
expi Increase Decrease In Litigation Contingency
IncreaseDecreaseInLitigationContingency
34000000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
20000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
158000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176516000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4408000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4193000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3150000
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
330000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4236000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5525000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1165000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1930000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12959000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11318000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
116281000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
134625000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1644000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4761000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1169000
us-gaap Payments Of Dividends
PaymentsOfDividends
22564000
us-gaap Payments Of Dividends
PaymentsOfDividends
20979000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138370000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150843000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-624000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25847000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14758000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169893000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195740000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174141000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2198000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2382000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
855000
expi Noncash Or Part Noncash Contingent Consideration For Disposition Of Business
NoncashOrPartNoncashContingentConsiderationForDispositionOfBusiness
1209000
expi Property Plant And Equipment Increase Due To Transfer Of Lease Asset
PropertyPlantAndEquipmentIncreaseDueToTransferOfLeaseAsset
1100000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
27000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><i style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;">Use of Estimates</i></p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><i style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;">Reclassifications</i></p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. Prior year segment and financial statement information has been reclassified to reflect Virbela as discontinued operations.</span></p>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120141000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
54000000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174141000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125873000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
44020000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169893000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130432000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65308000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195740000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
806000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
991000
CY2024Q3 expi Accounts Receivable Allowance For Credit Losses
AccountsReceivableAllowanceForCreditLosses
189000
CY2023Q4 expi Accounts Receivable Allowance For Credit Losses
AccountsReceivableAllowanceForCreditLosses
99000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
108000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
626000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
74000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
347000
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
988000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1964000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
5000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
11000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
1553000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
3469000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Assets
DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
3041000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Assets
DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
2089000
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
5587000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
7533000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
16000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
110000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
258000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
1699000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
274000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1809000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
274000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1809000
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1720000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
653000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
5694000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
911000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
818000
us-gaap Cost Of Revenue
CostOfRevenue
2500000
us-gaap Cost Of Revenue
CostOfRevenue
2335000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
102000
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
2469000
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
2165000
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
7778000
CY2024Q3 expi Disposal Group Including Discontinued Operation Technology And Development Expenses
DisposalGroupIncludingDiscontinuedOperationTechnologyAndDevelopmentExpenses
80000
CY2023Q3 expi Disposal Group Including Discontinued Operation Technology And Development Expenses
DisposalGroupIncludingDiscontinuedOperationTechnologyAndDevelopmentExpenses
256000
expi Disposal Group Including Discontinued Operation Technology And Development Expenses
DisposalGroupIncludingDiscontinuedOperationTechnologyAndDevelopmentExpenses
294000
expi Disposal Group Including Discontinued Operation Technology And Development Expenses
DisposalGroupIncludingDiscontinuedOperationTechnologyAndDevelopmentExpenses
765000
CY2024Q3 expi Disposal Group Including Discontinued Operation Sales And Marketing Expenses
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpenses
0
CY2023Q3 expi Disposal Group Including Discontinued Operation Sales And Marketing Expenses
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpenses
19000
expi Disposal Group Including Discontinued Operation Sales And Marketing Expenses
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpenses
-2000
expi Disposal Group Including Discontinued Operation Sales And Marketing Expenses
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpenses
73000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
1093000
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
3562000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
4957000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
10951000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-1093000
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-1842000
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-4304000
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-5257000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
6000
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
6000
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
17000
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
16000
CY2024Q3 expi Disposal Group Including Discontinued Operation Total Income
DisposalGroupIncludingDiscontinuedOperationTotalIncome
6000
CY2023Q3 expi Disposal Group Including Discontinued Operation Total Income
DisposalGroupIncludingDiscontinuedOperationTotalIncome
6000
expi Disposal Group Including Discontinued Operation Total Income
DisposalGroupIncludingDiscontinuedOperationTotalIncome
17000
expi Disposal Group Including Discontinued Operation Total Income
DisposalGroupIncludingDiscontinuedOperationTotalIncome
16000
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1087000
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1836000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-4287000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-5241000
CY2024Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
938000
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-920000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1070000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1851000
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2025000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-916000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3217000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3390000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.04
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2024Q3 expi Depreciable Property And Equipment Gross
DepreciablePropertyAndEquipmentGross
43960000
CY2023Q4 expi Depreciable Property And Equipment Gross
DepreciablePropertyAndEquipmentGross
39698000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33398000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27733000
CY2024Q3 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
10562000
CY2023Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
11965000
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
5000
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
11000
CY2024Q3 expi Assets Under Development
AssetsUnderDevelopment
931000
CY2023Q4 expi Assets Under Development
AssetsUnderDevelopment
1013000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11488000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12967000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1937000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2136000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5887000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6299000
CY2024Q3 us-gaap Goodwill
Goodwill
19866000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10894000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4572000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6322000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10734000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3722000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7012000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
442000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
654000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1855000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1849000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189947235
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177900083
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183606708
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
95037
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
610132
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
320481
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
802939
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
192559288
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180883383
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
192559288
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180883383
CY2022Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
3885000
CY2023 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
3832000
CY2023 expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
2717000
CY2023Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5000000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
2179000
expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
806000
CY2024Q3 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
6373000
CY2018Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2019Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2019Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2023Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
36213862
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24311897
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28937671
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2794040
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2761943
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
10070231
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
8257049
CY2023Q3 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
10728
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
10728
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39007902
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27084568
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39007902
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27084568
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1231187000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1212793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3469485000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3292362000
CY2024Q3 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
23942000
CY2023Q3 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
20792000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
67797000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
62263000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2379000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2790000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7742000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8148000
CY2024Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18000000
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
34000000
CY2024Q3 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
9910000
CY2023Q3 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
11764000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
28067000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
29912000
CY2024Q3 expi Stock Option Plan Expense Continuing And Discontinuing
StockOptionPlanExpenseContinuingAndDiscontinuing
1987000
CY2023Q3 expi Stock Option Plan Expense Continuing And Discontinuing
StockOptionPlanExpenseContinuingAndDiscontinuing
2533000
expi Stock Option Plan Expense Continuing And Discontinuing
StockOptionPlanExpenseContinuingAndDiscontinuing
5959000
expi Stock Option Plan Expense Continuing And Discontinuing
StockOptionPlanExpenseContinuingAndDiscontinuing
7659000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8334000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3705000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7971000
us-gaap Operating Income Loss
OperatingIncomeLoss
16544000
CY2024Q3 us-gaap Goodwill
Goodwill
19866000
CY2023Q4 us-gaap Goodwill
Goodwill
16982000
CY2024Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-6481000
CY2024Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-6481000
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
2265000
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
2265000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-8545000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-8545000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
15614000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
15614000
CY2024Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-2025000
CY2024Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-2025000
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-916000
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-916000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-3217000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-3217000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-3390000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-3390000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153259842
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153392005
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153858160
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153065727
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4791883
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3769258
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153259842
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158183888
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153858160
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156834985
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.04
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4153812
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192684
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3309505
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
679425
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000.0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.696
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.159
us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
34000000
CY2024Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
34000000.0
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
18000000.0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
expi-20240930x10q_htm.xml Edgar Link completed
0001558370-24-014851-index-headers.html Edgar Link pending
0001558370-24-014851-index.html Edgar Link pending
0001558370-24-014851.txt Edgar Link pending
0001558370-24-014851-xbrl.zip Edgar Link pending
expi-20240930.xsd Edgar Link pending
expi-20240930x10q.htm Edgar Link pending
expi-20240930x10q001.jpg Edgar Link pending
expi-20240930xex31d1.htm Edgar Link pending
expi-20240930xex31d2.htm Edgar Link pending
expi-20240930xex32d1.htm Edgar Link pending
expi-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
expi-20240930_def.xml Edgar Link unprocessable
expi-20240930_lab.xml Edgar Link unprocessable
expi-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
expi-20240930_cal.xml Edgar Link unprocessable